Q4FY17 Results : Sanofi India
Sanofi India Ltd. reported its results for the quarter ended March 31, 2017 on Friday. The consolidated numbers were largely negative.
Total sales for this quarter, Q4FY17, came in at Rs. 512.7 crore. This represents a 9.2 per cent sequential decline and 1.1 per cent YoY decline.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 36 crore and the EBIT margin stood at 7.02 per cent.
The company reported PAT worth Rs. 60 crore which represents a sequential QoQ increase of 12.8 per cent and a YoY decline of 27.4 per cent.
The stock opened at Rs. 4233 and touched an intra-day low of Rs. 4140 and finally closed at Rs. 4175 on BSE on Friday.
Sanofi India Ltd. is a pharmaceutical company. The company’s product portfolio includes medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine.